a public good project by the
Synthesis
Company
of California

© 2026

Masayoshi Harigai | doi.page

0 works0 citations0 h-index

Masayoshi Harigai

Tokyo Women's Medical University(JP)International University of Health and Welfare(JP)

Publications by Year

Research Areas

Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Vasculitis and related conditions, Chronic Lymphocytic Leukemia Research, Autoimmune and Inflammatory Disorders Research

Most-Cited Works

→ Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)(2013)848 cited
Identification of a p53-dependent negative response element in the bcl-2 gene.(1994)
→ Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis(2007)412 cited
→ Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis(2022)332 cited
→ Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17β-Estradiol in Breast Cancer Cells(1999)257 cited
→ Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis(2018)225 cited
→

Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study

(2014)

216 cited

→ Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan(2013)210 cited

→ Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients(2011)189 cited

→ Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan(2009)183 cited